rebeccamycin has been researched along with daunorubicin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anizon, F; Bailly, C; Chaires, JB; Goossens, JF; Laine, W; Prudhomme, M; Ren, J | 1 |
| Hasegawa, M; Kondoh, M; Watari, A; Yagi, K | 1 |
2 other study(ies) available for rebeccamycin and daunorubicin
| Article | Year |
|---|---|
Formaldehyde-induced alkylation of a 2'-aminoglucose rebeccamycin derivative to both A.T and G.C base pairs in DNA.
Topics: Alkylation; Aminoglycosides; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Carbazoles; Cross-Linking Reagents; Daunorubicin; DNA; Electrophoresis, Polyacrylamide Gel; Fluorescence; Formaldehyde; Indoles; Nucleic Acid Denaturation | 2000 |
Checkpoint Kinase 1 Activation Enhances Intestinal Epithelial Barrier Function via Regulation of Claudin-5 Expression.
Topics: Caco-2 Cells; Carbazoles; Checkpoint Kinase 1; Claudin-5; Daunorubicin; Enzyme Activation; Gene Expression Regulation, Neoplastic; Humans; Intestinal Mucosa; Protein Kinases | 2016 |